CDC study finds RSV vaccines protect older adults from hospitalization
The Centers for Disease Control and Prevention Sept. 4 published a study in JAMA which found older adults who receive a respiratory syncytial virus vaccine are 75% less likely to be hospitalized from RSV compared to those who don’t. The CDC last month updated RSV vaccine guidance for adults 60 and older, recommending those aged 60-74 at risk for RSV and all aged 75 and older receive one dose of the GSK, Pfizer or Moderna vaccine. Those who previously received a dosage should not seek another.
Related News Articles
Blog
Even before the COVID pandemic, the mental health and wellness of our young people was failing. The pandemic exacerbated the crisis and made it difficult for…
Headline
A new AHA video highlights how Corewell Health is transforming youth behavioral health care access in rural Michigan through school-based clinics and…
Headline
The AHA has updated the Stress and Coping Resources website, which contains valuable information and resources to support mental well-being for both health…
Headline
Jason Lesandrini, Ph.D., assistant vice president of ethics, advanced care planning, spiritual health and language access services at Wellstar Health System,…
Blog
When I delivered my first baby in 2016, I did not understand how I would feel postpartum. Though I had many family members who had experienced birth and…
Headline
The AHA's Advancing Health podcast recently celebrated the end of 2024 by releasing highlights from some of its most popular episodes of the year. The roundup…